MANHATTAN (CN) – Rockefeller University claims Ligand Pharmaceuticals owes it $2 million under a 1992 licensing agreement for technology used to screen for therapeutic drugs. It claims Ligand got big payouts from GlaxoSmithKline for drugs discovered with the technology, but refused to pay up, in New York County Court. Ligand contests this, in its own claim in San Diego Federal Court.
- N.Y. Appellate Divisions
- Allstate Faces Class-Action Over Seat Belts